Purpose: To evaluate the dose-effect relationship for medial rectus muscle advancement in patients with consecutive exotropia.
Methods: Pre- and postoperative deviations 1 day and 6 months after surgery were measured by linear strabismometric method. The change in deviation (difference between preoperative and postoperative deviation at 6 months) was correlated to the surgical dose (dose-effect relationship) and the preoperative distance deviation by multiple regression analysis. Multivariate regression analysis was performed with three and two independent variables (preoperative distance deviation, millimeters of advancement, intraoperative muscle stretch test), with change in deviation as a dependent variable.
Results: Twenty-four patients (mean age, 33 years; range, 18-60 years) were included. The mean preoperative deviation was 32(∆), the mean postoperative deviation was 0(∆) at day 1, and 9(∆) 6 months after surgery. The mean dose-effect relationship was 5(∆)/mm at day 1 and 4(∆)/mm 6 months after surgery. Mean exodrift 6 months after surgery was 9(∆). The univariate model was statistically significant for each variable (P < 0.05). The multivariate model was statistically significant for preoperative distance deviation and millimeters of advancement (P < 0.05) but not for intraoperative muscle stretch test (P = 0.1519).
Conclusions: The dose-effect relationship at 6 months after advancement of the medial rectus muscle for consecutive exotropia could be a useful guide for planning surgical correction, even considering the expected exodrift.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jaapos.2011.08.011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Stability of probiotic microcapsules produced through complex coacervation based on whey protein-gum arabic coupled with double emulsification: Role of krill oil in middle oil phase.
Int J Biol Macromol
January 2025
Sericultural and Agrifood Res Inst, Guangdong Academy of Agricultural Sciences, Guangzhou 510610, China.
The objective of this study was to prepare a microcapsule system composed of the inner microenvironment (probiotics), middle oil layer (soybean oil and polyglycerol polyricinoleate) and outer coacervate (whey protein and gum arabic) using double emulsification technique coupled with complex coacervation to encapsulate probiotics, and to evaluate the effect of adding krill oil (KO) to the middle oil layer on microcapsule structure and probiotic stability. The results of Fourier transform infrared spectroscopy and Scanning electron microscopy confirmed that whey protein may capture phospholipids in KO through hydrogen bonds, resulting in the formation of a more compact coacervate. Due to the compact coacervate enhanced the vapor transport barrier and reduced water evaporation during low-temperature dehydration, probiotics encapsulated in KO-supplemented microcapsules revealed less cell damage and a higher survival rate after freeze-drying.
View Article and Find Full Text PDFPopulation exposure-response analysis of the effect of ritlecitinib on eyebrow assessment and eyelash assessment in patients with alopecia areata.
CPT Pharmacometrics Syst Pharmacol
January 2025
Pfizer Inc., Paris, France.
Ritlecitinib is an orally bioavailable, small molecule that has been approved by the U.S. Food and Drug Administration (FDA) as a once-daily oral treatment option for people 12 years of age and older with severe alopecia areata.
View Article and Find Full Text PDFProton radiotherapy significantly reduces pneumonia in oesophageal cancer patients.
Int J Radiat Oncol Biol Phys
January 2025
Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Electronic address:
Background: Neoadjuvant chemoradiotherapy (nCRT) followed by surgical resection is the current standard of care for oesophageal cancer (EC) patients. This treatment is associated with a variety of complications, with pneumonia being the most common. We hypothesize that proton radiotherapy (PRT) can significantly reduce the incidence of pneumonia compared to photon radiotherapy (PhRT).
View Article and Find Full Text PDFLower urinary tract sub-structures as predictors of late urinary toxicity in concurrent chemo-radiotherapy for anal cancer.
Radiother Oncol
January 2025
Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.
Background And Purpose: Late toxicity is substantial after chemotherapy for anal cancer. This study aimed to investigate the relationship between radiation dose to lower urinary tract sub-structures and the risk of late urinary toxicities, in patients with anal cancer treated with chemoradiotherapy or radiotherapy.
Materials And Methods: From 2015 to 2021, 314 patients with localized anal cancer were included in a national prospective registration study.
The potential of urinary miR-200c-3p as a biomarker of fluorosis in rats.
Ecotoxicol Environ Saf
January 2025
Key Lab of Etiology and Epidemiology, Education Bureau of Heilongjiang Province & Ministry of Health (23618504), Center for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin, Heilongjiang Province 150081, China. Electronic address:
Fluorine is a strong oxidizing element and excessive intake can have harmful effects, particularly on the body's calcified tissues. Recent studies have demonstrated a link between miRNA and fluorosis. This study aimed to evaluate the time-dose-effect relationship of miR-200c-3p in plasma, urine and cartilage of rats with drinking water fluorosis, and to explore its potential as a biomarker.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!